Core Viewpoint - H2O America has appointed Nicholas Whitley as vice president of business development to lead strategic growth initiatives in the water and wastewater sector [1][2]. Group 1: Appointment and Role - Nicholas Whitley will oversee business development initiatives aimed at expanding H2O America's water and wastewater footprint [1]. - His role includes identifying, evaluating, and executing strategic growth opportunities to support long-term sustainable growth [1]. Group 2: Experience and Background - Whitley brings over 20 years of experience in corporate development, mergers and acquisitions, and infrastructure investing across various sectors [2]. - He previously served as managing director of business development at NW Natural Holdings, where he led over 30 acquisitions, transforming the company into a diversified infrastructure holding [2][3]. - His past roles include senior positions at GE Oil & Gas and investment banking at Nomura International and Houlihan Lokey, focusing on complex transactions [3]. Group 3: Company Overview - H2O America is a national investor-owned network of local water and wastewater utilities, serving over 1.6 million people through its regional utilities [5][7]. - The company emphasizes the importance of delivering clean, high-quality water and invests in critical infrastructure to ensure sustainable water supply [6].

Group 1 - Scott Adelson is the CEO of Houlihan Lokey and has over 35 years of experience with the firm, previously serving as Co-President and Global Head of Corporate Finance [1] - Anthony Martino is the Global Co-Head of Capital Solutions at Houlihan Lokey, focusing on raising debt and equity capital, and has been with the firm since 2013 [2]

Core Insights - WSP Global has signed an agreement to acquire TRC Companies for $3.3 billion, enhancing its capabilities in the power and energy sector [1][2] - The acquisition is expected to close in Q1 2026, subject to regulatory approvals [2] - This strategic move aligns with WSP's 2025-2027 Strategic Plan and aims to position the company as a leader in power and energy consulting [4] Financial Impact - The all-cash deal is valued at $3.3 billion and is projected to add low- to mid-single digit percentage to WSP's adjusted net earnings per share before synergies [2][3] - Post-acquisition, WSP will have approximately 27,000 employees in the US, contributing to 34% of its US revenue [3] Strategic Rationale - The acquisition will broaden WSP's expertise across water, infrastructure, and environmental services, addressing the rising demand for power consumption driven by AI and cryptocurrency sectors [2] - WSP aims to create an integrated platform with industry-leading capabilities in advisory, engineering, and program management through this acquisition [5][6] Advisory and Legal Support - J.P. Morgan and CIBC Capital Markets are serving as financial advisors for WSP, with legal counsel from Skadden, Arps, Slate, Meagher & Flom in the US and Stikeman Elliott in Canada [6] - Harris Williams, UBS Investment Bank, AEC Advisors, and Houlihan Lokey are advising TRC, with legal counsel from Paul, Weiss, Rifkind, Wharton & Garrison [7]

Financial Distress - Amara, a Spanish distributor of renewable energy products, is facing pressure on its cash flows [1] Advisory Engagement - Amara is working with financial advisor Houlihan Lokey [1]

Core Insights - Houlihan Lokey announced that Scott Adelson and Anthony Martino will present at Goldman Sachs' U.S. Financial Services Conference on December 9, 2025 [1] Company Information - The presentation will feature key insights from Houlihan Lokey's leadership, indicating the company's active engagement in the financial services sector [1] Industry Context - The participation in Goldman Sachs' conference highlights the importance of financial services events for networking and showcasing expertise within the industry [1]

Core Viewpoint - Investors are seeking growth stocks that can deliver above-average growth and exceptional returns, but identifying such stocks is challenging due to inherent volatility and risks [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system aids in identifying promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - Houlihan Lokey (HLI) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is crucial for investors, with double-digit growth being a strong indicator of future stock price gains [3] - Houlihan Lokey's historical EPS growth rate is 2.5%, but projected EPS growth for this year is 24.1%, surpassing the industry average of 19% [4] Group 3: Cash Flow Growth - Higher-than-average cash flow growth is essential for growth-oriented companies, allowing them to expand without relying on external funding [5] - Houlihan Lokey's year-over-year cash flow growth is 40.3%, significantly higher than the industry average of -3.5% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 15.9%, compared to the industry average of 11.7% [6] Group 4: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with near-term stock price movements [7] - Current-year earnings estimates for Houlihan Lokey have been revised upward, with the Zacks Consensus Estimate increasing by 2.2% over the past month [8] Group 5: Overall Assessment - Houlihan Lokey has achieved a Zacks Rank 2 and a Growth Score of A, positioning it well for potential outperformance in the market [9]

Core Insights - Houlihan Lokey Inc. (HLI) has achieved a total return of 44% since January 24, 2024, outperforming the S&P 500 [1] Group 1 - The total return of Houlihan Lokey Inc. (HLI) is significantly higher than that of the S&P 500 during the same period [1]

Core Insights - ARC Health has secured a $182 million credit facility to refinance existing debt and support growth initiatives in the US [1][2] - The company aims to expand its presence and improve behavioral health services across important regions in the US [2] - Thurston Group, a private equity firm, supports ARC Health's growth strategy and the establishment of the new credit facility [3][4] Company Overview - Founded in 2021 and based in Cleveland, Ohio, ARC Health is an outpatient behavioral health provider [1] - The company operates 91 locations across 20 US states and employs over 1,300 clinicians [1] - ARC Health focuses on a data-driven, patient-centered model to achieve strong clinical and operational results [1] Growth Strategy - The new credit facility will provide ARC Health with the capital and flexibility needed for expansion and to support partner practices [2] - The acquisition of Mindsoother Therapy Center in January 2024 marks a significant step in ARC Health's growth journey [4]

Core Viewpoint - Growth stocks are appealing due to their potential for above-average financial growth, but identifying strong candidates involves navigating inherent risks and volatility [1] Group 1: Company Overview - Houlihan Lokey (HLI) is highlighted as a recommended growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 2.5%, but projected EPS growth for the current year is expected to be 24.1%, surpassing the industry average of 19% [4] Group 2: Financial Metrics - Cash flow growth for Houlihan Lokey stands at 40.3% year-over-year, significantly higher than the industry average of -2.5% [5] - The company's annualized cash flow growth rate over the past 3-5 years is 15.9%, compared to the industry average of 12% [6] Group 3: Earnings Estimates - There has been a positive trend in earnings estimate revisions for Houlihan Lokey, with the Zacks Consensus Estimate for the current year increasing by 1.8% over the past month [7] - The combination of a Growth Score of A and a Zacks Rank of 2 indicates that Houlihan Lokey is positioned as a potential outperformer for growth investors [9]

Financial Performance - Revenues for Q3 2025 were $659.5 million, a 15% increase from $575.0 million in Q3 2024[94] - Net income for Q3 2025 was $111.8 million, a 19% increase from $93.5 million in Q3 2024[94] - Revenues for the six months ended September 30, 2025, were $1.26 billion, a 16% increase from $1.09 billion in the same period of 2024[99] - Net income for the six months ended September 30, 2025, was $209.3 million, a 15% increase from $182.5 million in 2024[128] - Total revenues for the six months ended September 30, 2025, were $1,264.8 million, representing a 16% increase compared to $1,088.6 million for the same period in 2024[1] Operating Expenses - Total operating expenses for Q3 2025 were $508.1 million, up 14% from $444.3 million in Q3 2024[96] - Total operating expenses for the six months ended September 30, 2025, were $1,023.7 million, up 19% from $863.2 million in the same period of 2024[100] - Compensation expenses in Q3 2025 were $423.2 million, reflecting a 17% increase compared to $360.6 million in Q3 2024[96] - Compensation expenses for the six months ended September 30, 2025, were $816.0 million, an 18% increase from $690.8 million in the same period of 2024[100] - Corporate expenses increased by 21% to $71.5 million for the three months ended September 30, 2025, compared to $59.3 million for the same period in 2024[119] Profitability Metrics - The Compensation Ratio for Q3 2025 was 64.2%, compared to 62.7% in Q3 2024[96] - Total segment profit for the six months ended September 30, 2025, was $410.6 million, an 18% increase compared to $347.2 million for the same period in 2024[1] - Segment profit for Corporate Finance rose by 34% to $147.3 million for the three months ended September 30, 2025, compared to $109.7 million for the same period in 2024[108] - Segment profit for Financial Restructuring decreased by 18% to $50.1 million for the three months ended September 30, 2025, compared to $60.9 million for the same period in 2024[112] - Segment profit for Financial and Valuation Advisory increased by 31% to $25.4 million for the three months ended September 30, 2025, compared to $19.4 million for the same period in 2024[116] Tax and Other Income - The effective tax rate for Q3 2025 was 30.2%, down from 31.3% in Q3 2024[98] - Other (income) expense, net for Q3 2025 was $(8.7) million, compared to $(5.4) million in Q3 2024, primarily due to higher interest income[97] Cash Flow and Investments - Operating cash flows provided $193.4 million, down 14% from $224.7 million in the same period of 2024[129][130] - Investing activities resulted in a net outflow of $4.6 million, significantly reduced by 94% compared to $71.3 million in 2024[129][130] - Financing activities showed a net outflow of $268.8 million, an increase of 34% from $200.6 million in 2024, primarily due to employee tax obligations and dividends[129][130] - Cash, cash equivalents, and restricted cash at the end of the period totaled $928.4 million, a 34% increase from $692.9 million in 2024[128] Foreign Currency Impact - The company experienced an 80% increase in the effects of exchange rate changes on cash, from $18.2 million in 2024 to $32.8 million in 2025[128] - The net impact of foreign currency fluctuations on other comprehensive income was $34.3 million for the six months ended September 30, 2025, compared to $28.4 million in 2024[139] - A hypothetical 10% depreciation in the U.S. Dollar would have resulted in an increase in other comprehensive income of approximately $103 million for the six months ended September 30, 2025[139] - The company had no open foreign currency forward contracts as of September 30, 2025, compared to two contracts with a notional value of $37.0 million in 2024[141] Accounting Policies - There were no significant changes to critical accounting policies and estimates during the reporting period[133]